Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	86	98	66	67	104	144
Market Cap Growth	48.65%	48.65%	-1.17%	-35.77%	-27.72%	56.56%
Enterprise Value	83	101	69	64	105	143
Last Close Price	6.24	7.15	4.85	4.92	7.68	10.73
PE Ratio	18.88	20.85	-	-	189.51	396.90
Forward PE	28.32	119.17	-	-	42.95	77.31
PS Ratio	1.50	1.72	1.32	1.24	2.12	3.50
PB Ratio	22.79	25.98	-34.65	14.39	11.42	19.34
P/TBV Ratio	25.01	28.51	-	15.51	11.85	20.26
P/FCF Ratio	12.29	14.01	-	60.64	25.25	-
P/OCF Ratio	11.64	13.27	-	16.80	15.99	-
PEG Ratio	-	-	-	-	2.86	5.44
EV/Sales Ratio	1.45	1.78	1.38	1.19	2.13	3.48
EV/EBITDA Ratio	12.72	15.65	-	-	46.90	92.05
EV/EBIT Ratio	17.03	20.94	-	-	172.63	389.82
EV/FCF Ratio	11.79	14.51	-	58.12	25.48	-
Debt / Equity Ratio	1.68	1.68	-3.90	1.86	1.04	1.29
Debt / EBITDA Ratio	0.76	0.76	-	-	2.29	3.37
Debt / FCF Ratio	0.90	0.90	-	7.82	2.30	-
Asset Turnover	1.95	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.88	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.94	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	503.05%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	10.36%	10.36%	-14.31%	-7.98%	1.21%	0.95%
Return on Capital (ROIC)	38.77%	38.77%	-46.11%	-17.49%	2.13%	1.76%
Return on Capital Employed (ROCE)	57.10%	57.10%	-	-	3.40%	2.20%
Earnings Yield	5.47%	4.80%	-11.04%	-8.00%	0.53%	0.25%
FCF Yield	8.14%	7.14%	-10.58%	1.65%	3.96%	-3.45%
Buyback Yield / Dilution	-5.31%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q